Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,520,444
Closed -$1.7B 5785
2026
Q1
$1.7B Buy
22,520,444
+422,027
+2% +$31.7M 0.03% 463
2025
Q4
$1.65B Buy
22,098,417
+2,684,716
+14% +$196M 0.03% 479
2025
Q3
$1.31B Sell
19,413,701
-527,670
-3% -$35M 0.02% 575
2025
Q2
$1.3B Sell
19,941,371
-1,423,462
-7% -$85.3M 0.02% 540
2025
Q1
$1.32B Sell
21,364,833
-861,238
-4% -$57.1M 0.03% 511
2024
Q4
$1.6B Sell
22,226,071
-408,794
-2% -$31.9M 0.03% 458
2024
Q3
$1.84B Sell
22,634,865
-464,071
-2% -$37.1M 0.04% 408
2024
Q2
$1.72B Sell
23,098,936
-295,303
-1% -$22.1M 0.04% 400
2024
Q1
$1.82B Sell
23,394,239
-869,946
-4% -$64.7M 0.04% 395
2023
Q4
$1.73B Buy
24,264,185
+39,851
+0.2% +$2.77M 0.04% 382
2023
Q3
$1.68B Buy
24,224,334
+374,786
+2% +$28.3M 0.05% 359
2023
Q2
$1.93B Buy
23,849,548
+87,374
+0.4% +$7.14M 0.05% 338
2023
Q1
$1.92B Buy
23,762,174
+282,787
+1% +$22.8M 0.06% 326
2022
Q4
$1.76B Buy
23,479,387
+82,304
+0.4% +$5.86M 0.06% 343
2022
Q3
$1.51B Buy
23,397,083
+345,453
+1% +$23.9M 0.05% 359
2022
Q2
$1.6B Buy
23,051,630
+1,237,618
+6% +$91.9M 0.05% 351
2022
Q1
$1.68B Sell
21,814,012
-74,266
-0.3% -$5.34M 0.05% 397
2021
Q4
$1.68B Buy
21,888,278
+532,526
+2% +$39.1M 0.04% 427
2021
Q3
$1.58B Sell
21,355,752
-160,977
-0.7% -$12.1M 0.04% 420
2021
Q2
$1.44B Buy
21,516,729
+454,616
+2% +$30.4M 0.04% 459
2021
Q1
$1.57B Buy
21,062,113
+223,811
+1% +$17M 0.05% 404
2020
Q4
$1.52B Buy
20,838,302
+808,123
+4% +$57M 0.05% 376
2020
Q3
$1.33B Sell
20,030,179
-168,095
-0.8% -$10.6M 0.05% 361
2020
Q2
$1.15B Sell
20,198,274
-1,012,080
-5% -$49.7M 0.05% 388
2020
Q1
$744M Sell
21,210,354
-785,378
-4% -$37.4M 0.04% 464
2019
Q4
$1.15B Buy
21,995,732
+1,736,375
+9% +$86.4M 0.04% 412
2019
Q3
$1.02B Buy
20,259,357
+1,649,804
+9% +$81.2M 0.04% 427
2019
Q2
$894M Buy
18,609,553
+95,737
+0.5% +$4.43M 0.04% 470
2019
Q1
$896M Sell
18,513,816
-189,647
-1% -$8.55M 0.04% 457
2018
Q4
$769M Sell
18,703,463
-70,257
-0.4% -$2.88M 0.04% 464
2018
Q3
$769M Buy
18,773,720
+164,937
+0.9% +$6.67M 0.03% 523
2018
Q2
$740M Sell
18,608,783
-1,408,513
-7% -$54.2M 0.03% 523
2018
Q1
$748M Sell
20,017,296
-927,684
-4% -$37.5M 0.04% 517
2017
Q4
$895M Sell
20,944,980
-2,003,795
-9% -$79.9M 0.04% 448
2017
Q3
$842M Buy
22,948,775
+296,682
+1% +$12M 0.04% 438
2017
Q2
$1.03B Buy
22,652,093
+378,892
+2% +$16.7M 0.05% 362
2017
Q1
$948M Buy
22,273,201
+21,472,032
+2,680% +$875M 0.05% 374
2016
Q4
$32.1M Buy
801,169
+158,372
+25% +$6.11M 0.05% 423
2016
Q3
$25M Buy
642,797
+43,636
+7% +$1.65M 0.04% 494
2016
Q2
$20.7M Buy
599,161
+182,091
+44% +$6.31M 0.03% 531
2016
Q1
$14.4M Buy
417,070
+144,721
+53% +$5.05M 0.02% 586
2015
Q4
$10.5M Buy
272,349
+90,562
+50% +$3.52M 0.02% 664
2015
Q3
$7.11M Buy
181,787
+7,592
+4% +$301K 0.01% 704
2015
Q2
$6.63M Sell
174,195
-35,592
-17% -$1.25M 0.01% 763
2015
Q1
$6.93M Buy
209,787
+78,240
+59% +$2.4M 0.01% 760
2014
Q4
$3.52M Buy
131,547
+12,011
+10% +$310K 0.01% 920
2014
Q3
$2.91M Buy
119,536
+3,742
+3% +$94.5K ﹤0.01% 974
2014
Q2
$2.94M Sell
115,794
-16,523
-12% -$386K ﹤0.01% 969
2014
Q1
$2.85M Sell
132,317
-8,451
-6% -$182K ﹤0.01% 970
2013
Q4
$3.15M Buy
140,768
+8,105
+6% +$179K 0.01% 928
2013
Q3
$2.74M Buy
132,663
+4,827
+4% +$103K 0.01% 900
2013
Q2
$2.47M Buy
+127,836
New +$2.67M ﹤0.01% 894

Other funds holding HOLX

BlackRock's HOLX Position: Q2 2026 in Review

BlackRock sold out of Hologic (HOLX) in Q2 2026, closing a stake of 22,520,444 shares — an estimated $1.7B sold.

BlackRock first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $1.93B in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • BlackRock reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • BlackRock sold 22,520,444 Hologic shares in Q2 2026, an estimated $1.7B.
  • BlackRock first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • BlackRock's Hologic position peaked at $1.93B in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.